Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2015
  • Online publication date: May 2015

Chapter 13 - Optical coherence tomography and retinal segmentation in neurological diseases

Related content

Powered by UNSILO
1.Frohman, EM, Fujimoto, JG, Frohman, TC, Calabresi, PA, Cutter, G, Balcer, LJ. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 2008; 4:664–75.
2.Debuc, DC. A review of algorithms for segmentation of retinal image data using optical coherence tomography. In: Ho, P-G, editor. Image Segmentation: InTech; 2011.
3.Cettomai, D, Pulicken, M, Gordon-Lipkin, E, Salter, A, Frohman, TC, Conger, A, et al. Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol 2008; 65:1218–22.
4.Syc, SB, Warner, CV, Hiremath, GS, Farrell, SK, Ratchford, JN, Conger, A, et al. Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler 2010; 16:829–39.
5.Saidha, S, Syc, SB, Ibrahim, MA, Eckstein, C, Warner, CV, Farrell, SK, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011; 134:518–33.
6.Seigo, MA, Sotirchos, ES, Newsome, S, Babiarz, A, Eckstein, C, Ford, E, et al. In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol 2012; 259:2119–30.
7.Balcer, LJ. Clinical practice. Optic neuritis. N Engl J Med 2006; 354:1273–80.
8.Toussaint, D, Perier, O, Verstappen, A, Bervoets, S. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 1983; 3:211–20.
9.Ikuta, F, Zimmerman, HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology 1976; 26:26–8.
10.Shindler, KS, Ventura, E, Dutt, M, Rostami, A. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res 2008; 87:208–13.
11.Kerrison, JB, Flynn, T, Green, WR. Retinal pathologic changes in multiple sclerosis. Retina 1994; 14:445–51.
12.Green, AJ, McQuaid, S, Hauser, SL, Allen, IV, Lyness, R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 2010; 133:1591–601.
13.Papakostopoulos, D, Fotiou, F, Hart, JC, Banerji, NK. The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol 1989; 74:110.
14.Forooghian, F, Sproule, M, Westall, C, Gordon, L, Jirawuthiworavong, G, Shimazaki, K, et al. Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol 2006; 113:123–32.
15.Gundogan, FC, Demirkaya, S, Sobaci, G. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?–A structural and functional evaluation. Invest Ophthalmol Vis Sci 2007; 48:5773–81.
16.Engell, T, Hvidberg, A, Uhrenholdt, A. Multiple sclerosis: periphlebitis retinalis et cerebro-spinalis. A correlation between periphlebitis retinalis and abnormal technetium brain scintigraphy. Acta Neurol Scand 1984; 69:293–7.
17.Sepulcre, J, Murie-Fernandez, M, Salinas-Alaman, A, Garcia-Layana, A, Bejarano, B, Villoslada, P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007; 68:1488–94.
18.Petzold, A, de Boer, JF, Schippling, S, Vermersch, P, Kardon, R, Green, A, et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 2010; 9:921–32.
19.Walter, SD, Ishikawa, H, Galetta, KM, Sakai, RE, Feller, DJ, Henderson, SB, et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 2012; 119:1250–7.
20.Warner, CV, Syc, SB, Stankiewicz, AM, Hiremath, G, Farrell, SK, Crainiceanu, CM, et al. The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS ONE 2011; 6:e22947.
21.Henderson, AP, Altmann, DR, Trip, AS, Kallis, C, Jones, SJ, Schlottmann, PG, et al. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Brain 2010; 133:2592–602.
22.Syc, SB, Saidha, S, Newsome, SD, Ratchford, JN, Levy, M, Ford, E, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 2012; 135:521–33.
23.Saidha, S, Syc, SB, Durbin, MK, Eckstein, C, Oakley, JD, Meyer, SA, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler 2011; 17:1449–63.
24.Saidha, S, Sotirchos, ES, Oh, J, Syc, SB, Seigo, MA, Shiee, N, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol 2013; 70:3443.
25.Zimmermann, H, Freing, A, Kaufhold, F, Gaede, G, Bohn, E, Bock, M, et al. Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler 2013; 19:443–50.
26.Talman, LS, Bisker, ER, Sackel, DJ, Long, DA, Jr., Galetta, KM, Ratchford, JN, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 2010; 67:749–60.
27.Garcia-Martin, E, Pueyo, V, Almarcegui, C, Martin, J, Ara, JR, Sancho, E, et al. Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients. Br J Ophthalmol 2011; 95:1577–82.
28.Henderson, AP, Trip, SA, Schlottmann, PG, Altmann, DR, Garway-Heath, DF, Plant, GT, et al. A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. J Neurol 2010; 257:1083–91.
29.Serbecic, N, Aboul-Enein, F, Beutelspacher, SC, Vass, C, Kristoferitsch, W, Lassmann, H, et al. High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years. PLoS ONE 2011; 6:e19843.
30.Ratchford, JN, Saidha, S, Sotirchos, ES, Oh, JA, Seigo, MA, Eckstein, C, et al. Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology 2013; 80:4754.
31.Gelfand, JM, Nolan, R, Schwartz, DM, Graves, J, Green, AJ. Microcystic macular edema in multiple sclerosis is associated with disease severity. Brain 2012; 135:1786–93.
32.Saidha, S, Sotirchos, ES, Ibrahim, MA, Crainiceanu, CM, Gelfand, JM, Sepah, YJ, et al. Microcystic macular edema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 2012; 11:963–72.
33.Sotirchos, ES, Saidha, S, Byraiah, G, Mealy, MA, Ibrahim, MA, Sepah, YJ, et al. In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 2013; 80:1406–14.
34.Gelfand, JM, Cree, BA, Nolan, R, Arnow, S, Green, AJ. Microcystic inner nuclear layer abnormalities and neuromyelitis optica. JAMA Neurol 2013; 70:629–33.
35.Balk, LJ, Killestein, J, Polman, CH, Uitdehaag, BM, Petzold, A. Microcystic macular edema confirmed, but not specific for multiple sclerosis. Brain 2012; 135:e226.
36.Abegg, M, Zinkernagel, M, Wolf, S. Microcystic macular degeneration from optic neuropathy. Brain 2012; 135:e225.
37.Barboni, P, Carelli, V, Savini, G, Carbonelli, M, La Morgia, C, Sadun, AA. Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain 2013; 136:e239.
38.Kisimbi, J, Shalchi, Z, Mahroo, OA, Mhina, C, Sanyiwa, AJ, Mabey, D, et al. Macular spectral domain optical coherence tomography findings in Tanzanian endemic optic neuropathy. Brain 2013.
39.Kaushik, M, Wang, CY, Barnett, MH, Garrick, R, Parratt, J, Graham, SL, et al. Inner Nuclear Layer Thickening Is Inversley Proportional to Retinal Ganglion Cell Loss in Optic Neuritis. PLoS ONE 2013; 8:e78341.
40.Levin, MH, Bennett, JL, Verkman, AS. Optic neuritis in neuromyelitis optica. Prog Retin Eye Res 2013.
41.Lucchinetti, CF, Mandler, RN, McGavern, D, Bruck, W, Gleich, G, Ransohoff, RM, et al. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 2002; 125:1450–61.
42.Naismith, RT, Tutlam, NT, Xu, J, Klawiter, EC, Shepherd, J, Trinkaus, K, et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 2009; 72:1077–82.
43.Ratchford, JN, Quigg, ME, Conger, A, Frohman, T, Frohman, E, Balcer, LJ, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 2009; 73:302–8.
44.Green, AJ, Cree, BA. Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry 2009; 80:1002–5.
45.Schneider, E, Zimmermann, H, Oberwahrenbrock, T, Kaufhold, F, Kadas, EM, Petzold, A, et al. Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis. PLoS ONE 2013; 8:e66151.
46.de Seze, J, Blanc, F, Jeanjean, L, Zephir, H, Labauge, P, Bouyon, M, et al. Optical coherence tomography in neuromyelitis optica. Arch Neurol 2008; 65:920–3.
47.Merle, H, Olindo, S, Donnio, A, Richer, R, Smadja, D, Cabre, P. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci 2008; 49:4412–7.
48.Monteiro, ML, Fernandes, DB, Apostolos-Pereira, SL, Callegaro, D. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using optical coherence tomography. Invest Ophthalmol Vis Sci 2012.
49.Ikram, MK, Cheung, CY, Wong, TY, Chen, CP. Retinal pathology as biomarker for cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2012; 83:917–22.
50.He, XF, Liu, YT, Peng, C, Zhang, F, Zhuang, S, Zhang, JS. Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer’s disease: a meta-analysis. Int J Ophthalmol 2012; 5:401–5.
51.Archibald, NK, Clarke, MP, Mosimann, UP, Burn, DJ. The retina in Parkinson’s disease. Brain 2009; 132:1128–45.
52.Archibald, NK, Clarke, MP, Mosimann, UP, Burn, DJ. Retinal thickness in Parkinson’s disease. Parkinsonism Relat Disord 2011; 17:431–6.
53.Roth, NM, Saidha, S, Zimmermann, H, Brandt, AU, Oberwahrenbrock, T, Maragakis, NJ, et al. Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur J Neurol 2013; 20:1170–6.